Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis

180 Metz, M., Ohanyan, T., Church, M. K.+, and Maurer, M.: Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis. J. Dermatol. Sci. 2014: 73; 57-62. IF: 3.42